The Recall Desk
Agency classClass IOur severity:SevereFDA (Devices)·Z-0789-2014·Announced 2014-01-29

Codman TRUFILL n-BCA Liquid Embolic System Recalled for Incorrect Instructions

Codman & Shurtleff, Inc. is recalling 7,983 units of the TRUFILL n-BCA Liquid Embolic System due to incorrect instructions for use.

The agency’s classification

FDA (Devices): Class I

Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The agency classified this recall as Class I — a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death. On that classification alone this is scored Severe; a score of Critical is reserved for recalls where a death or serious injury was reported. The agency gives the reason as: "Incorrect instructions for use (IFU)."

Plain-English summary

Codman & Shurtleff, Inc. is recalling 7,983 units of the TRUFILL n-Butyl Cyanoacrylate (n-BCA) Liquid Embolic System, Product Code 631-500. The recall is being conducted because the product contains incorrect instructions for use (IFU). The system is indicated for the embolization of cerebral arteriovenous malformations (AVMs) when pre-surgical devascularization is desired.

The affected units were distributed worldwide, including nationwide in the United States (including Puerto Rico), as well as to Costa Rica and Russia. The recall covers all lot codes. No specific illnesses or injuries are reported in the source text.

Healthcare providers and facilities should stop using the affected TRUFILL n-BCA Liquid Embolic System units and contact Codman & Shurtleff, Inc. for further instructions on how to return or dispose of the product.

The recalled product

Product
TRUFILL¿ n-Butyl Cyanoacrylate (n-BCA) Liquid Embolic System: One 1 g tube of n-BCA, one 10 mL vial of Ethiodized Oil and one 1 g vial of Tantalum Powder Product Code: 631-500 The TRUFILL n-BCA Liquid Embolic System is indicated for the embolization of cerebral…
Affected units
7,983

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All lot codes

Distribution

Distributed nationwide across the United States.

The notice also names 1 state specifically:

Part of a larger recall action

This product is one of 2 recalled by Codman & Shurtleff, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 2 products in this recall →

Similar recalls